Hemophagocytosis as a para-neoplastic syndrome in NK cell leukemia

International Journal of Hematology

Volumn 64, Issue 2, 1996, Pages 135-142

  Kobayashi, Yukio ^a,b   Uehara, Shoji ^a   Inamori, Ken ^c   Shirato, Risa ^a   Ozawa, Keiya ^a   Sklar, Jeffrey ^d   Asano, Shigetaka ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b National Cancer Center   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Hemophagocytic syndrome; Interferon ; LGL leukemia; NK cell leukemia

Indexed keywords

COLONY STIMULATING FACTOR 1; GAMMA INTERFERON; INTERLEUKIN 2;

ADOLESCENT; ARTICLE; BLOOD LEVEL; CASE REPORT; ERYTHROPHAGOCYTOSIS; FEMALE; HUMAN; HUMAN CELL; LEUKEMIA; NATURAL KILLER CELL; NATURAL KILLER CELL LEUKEMIA; PARANEOPLASTIC SYNDROME; PRIORITY JOURNAL;

EID: 0030219063     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1016/0925-5710(96)00477-x     Document Type: Article

References (38)

1. [1] Okuda T, Sakamoto S, Deguchi T, Misawa S, Kashima K, Yoshihara T, et al. Hemophagocytic syndrome associated with aggressive naural killer cell leukemia. Am J Hematol 1991;38:321-323.
2. [2] Imashuku S, Okuda T, Yoshihara T, Hibi S. Cytokine levels in aggressive natural killer cell leukaemia and malignant histiocytosis. Br J Haematol 1991;79:132-133.
3. [3] Fujiwara F, Hibi S, Imashuku S. Hypercytokinemia in hemophagocytic syndrome. Am J Pediatr Hematol Oncol 1993;15:92-98.
4. [4] Loughran TP Jr. Clonal diseases of large granular lymphocytes. Blood 1993;82:1-14.
5. [5] Kita M, Ohmoto Y, Hirai Y, Yamaguchi N, Imanishi J. Induction of cytokines in human peripheral blood mononuclear cells by mycoplasmas. Microbiol Immunol 1992;36:507-516.
6. [6] Sone S, Nakanishi M, Ohmoto Y, Yanagawa H, Ogura T. Macrophage colony-stimulating factor activity in malignant pleural effusions. Chest 1991;99:377-381.
7. [7] Oshimi K, Oshimi Y, Satake M, Mizoguchi H, Natural killer-mediated cell lysis of normal and malignant target cells, and its regulation by monocytes. J Exp Med 1985;162:472-486.
8. [8] Raab-Traub N, Flynn K. The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 1986;47:883-889.
9. [9] Cleary ML, Nalesnik MA, Shearer WT, Sklar J. Clonal analysis of transplant-associated lymphoproliferations based on the structure of the genomic termini of the Epstein-Barr virus. Blood 1988;72:349-352.
10. [10] Oshimi K, Yamada O, Kaneko T, Nishinarita S, Iizuka Y, Urabe A, et al. Laboratory findings and clinical courses of 33 patients with granular lymphocyte-proliferative disorders. Leukemia 1993;7:782-788.
11. [11] Ohno T, Kanoh T, Arita Y, Fujii H, Kuribayashi K, Masuda T, et al. Fulminant clonal expansion of large granular lymphocytes. Characterization of their morphology, phenotype, genotype, and function. Cancer 1988;62:1918-1927.
12. [12] Hart DNJ, Baker BW, Inglis MJ, Nimmo JC, Starling GC, Deacon E, et al. Epstein-Barr viral DNA in acute large granular lymphocyte (natural killer) leukemic cells. Blood 1992;79:2116-2123.
13. [13] Sheridan W, Winton EF, Chan WC, Gordon DS, Vogler WR, Phillips C, et al. Leukemia of non-T lineage natural killer cells. Blood 1988;72:1701-1707.
14. [14] Lanier LL, Spits H, Phillips JH. The developmental relationship between NIC cells and T cells. Immunol Today 1992;13:392-395.
15. [15] Kawa-Ha K, Ishihara S, Ninotniya T, Yumura-Yagi K, Hara J, Murayama F, et al. CD3-negative lymphoproliferative disease of granular lymphocytes containing Epstein-Barr viral DNA. J Clin Invest 1989;84:51-55.
16. [16] Loughran TP Jr, Zambello R, Ashley R, Guderian J, Pellenz M, Semenzato G, et al. Failure to detect Epstein-Barr virus DNA in peripheral blood mononuclear cells of most patients with large granular lynphocyte leukemia. Blood 1993;81:2723-2727.
17. [17] Falini B, Pileri S, DeSolas I, Martelli MF, Mason DY, Delsol G, et al. Peripheral T-cell lymphoma associated with hemophagocytic syndrome. Blood 1990;75: 434-444.
18. [18] Jaffe ES, Costa J, Fauci AS, Cossman J, Tsokos M. Malignant lymphoma and erythrophagocytosis simulating malignant histiocytosis. Am J Med 1983;75:741-749.
19. [19] Liang D-C, Chu ML, Shih C-C. Reactive histiocytosis in acute lymphoblastic leukemia and non-Hodgkin's lymphoma. Cancer 1986;58:1289-1294.
20. [20] Manoharan A, Catovsky D, Lampert IA, Mashadhani A, Gordon-Smith EC, Gallon DA. Histiocytic medullary reticulosis complicating chronic leukaemia; malignant or reactive? Scand J Haematol 1981;26:5-13.
21. [21] Takasaki N, Kaneko Y, Maseki N, Sakurai M, Shimamura K, Takayama S. Hemophagocytic syndrome complicating T-cell acute lymphoblastic leukemia with a novel t(11;14)(p15;q11) chromosome translocation. Cancer 1987;59:424-428.
22. [22] Myers TJ, Kessimian N, Schwartz S. Mediastinal germ cell tumor associated with the hemophagocytic syndrome. Ann Im Med 1988;109:504-505.
23. [23] Johnston RB Jr. Monocytes and macrophages. N Engl J Med 1988;318:747-758.
24. [24] Favara BE. Langerhans' cell histiocytosis pathobiology and pathogenesis. Semin Oncol 1991; 18:3-7.
25. [25] Levine EG, Hanson CA, Waclaw J, Peterson BA. True histiocytic lymphoma. Semin Oncol 1991;18:39-49.
26. [26] Vogelstein B, Fearon ER, Hamilton SR, Preisinger AC, Willard HF, Michelson AM, et al. Cancer Res 1987;47:4806-4813.
27. [27] Shiohara M, Koike K, Sawai N, Kasai S, Yang F-C, Yabuhara A, et al. Hemophagocytic syndrome with high level of interferon-γ in the advanced stage. Jpn J Clin Hematol 1993;34:1573-1578.
28. [28] Pace JL, Russell SW, Torres BA, Johnson HM, Gray PW. Recombinant mouse γ interferon induces the priming step in macrophage activation for tumor cell killing. J Immunol 1983;130:2011-2013.
29. [29] Gifford GE, Lohmann-Matthes M-L. Gamma interferon priming of mouse and human macrophages for induction of tumor necrosis factor production by bacterial lipopolysaccharide. J Natl Cancer Inst 1987;78:121-124.
30. [30] Bancroft GJ. The role of natural killer cells in innate resistance to infection. Curr Opin Immunol 1993;5:503-510.
31. [31] Kaye PM, Bancroft GJ. Leishmaniadonovani infection in scid mice: lack of tissue response and in vivo macrophage activation correlates with failure to trigger natural killer cell-derived gamma interferon production in vitro. Infect Immun 1992;60:4335-4342.
32. [32] Arai K, Lee F, Miyajima A, Miyatake S, Arai N, Yokota T. Cytokines: coordinators of immune and inflammatory responses. Ann Rev Biochem 1990;59:783-836.
33. [33] Metcalf D. The molecular biology and functions of the granulocyte-macrophage stimulating factors. Blood 1986;67:257-267.
34. [34] Demetri GD, Zenzie BW, Rheinwald JG, Griffin JD. Expression of colony-stimulating factor genes by normal human mesotherial cells and human malignant mesothelioma cell lines in vitro. Blood 1989;74:940-946.
35. [35] Vallenga E, Rambaldi A, Ernst TJ, Ostapovicz D, Griffin JD. Independent regulation of M-CSF and G-CSF gene expression in human monocytes. Blood 1988;71:1529-1532.
36. [36] Mendelsohn J. Principles of neoplasia. In: Wilson JD, Braunwald E, Isselbacher KJ, Petersdorf RG, Martin JB, Fauci AS, et al. (eds). Harrison's Principles of Internal Medicine. New York: McGraw-Hill, 1991;1576-1586.
37. [37] Hsu SM, Waldron JW Jr, Hsu P-L, Hough AJ Jr. Cytokines in malignant lymphomas: review and prospective evaluation. Hum Pathol 1993;24:1040-1057.
38. [38] Gruss H-J, Dower SK. Tumor necrosis factor ligand superfamily: involvement in the pathology of malignant lymphomas. Blood 1995;85:3378-3404.